(IN BRIEF) SCHOTT Pharma has launched the industry’s first 5.5 ml prefillable staked-needle glass syringe, expanding its syriQ BioPure® platform to support biologic therapies designed for home administration. The syringe integrates seamlessly with Ypsomed’s YpsoMate® 5.5 ml autoinjector and Datwyler’s … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, autoinjector, biologic therapies, biopharmaceuticals, chronic disease treatment, CPHI Frankfurt, Datwyler, drug delivery, glass syringe, Healthcare Innovation, homecare, large-volume injector, medical technology, patient care, pharmaceutical innovation, SCHOTT Pharma, SCHOTT Pharma and Ypsomed drive innovation in large-volume injectable drug delivery with new 5.5 ml syringe, SCHOTT Pharma unveils 5.5 ml BioPure glass syringe to advance home-based biologic treatments, Subcutaneous Injection, syriQ BioPure, tungsten-free syringe, Ulrike Bauer, YpsoMate, Ypsomed
(IN BRIEF) Alcura France, a fully owned subsidiary of Mutares SE & Co. KGaA, has received a firm acquisition proposal for its home healthcare services division (PSAD) from Santé Cie Group, a key European provider of homecare and ambulatory services. … Read the full press release
Posted in Business, Financial, France, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged 2024 revenue, acquisition offer, Alcura France, ambulatory care, CIO, EUR 17 million, home healthcare services, homecare, Johannes Laumann, M&A, MA&D, maintien à domicile, Mutares SE & Co. KGaA, partnership, PSAD, Santé Cie Group, shareholder returns, works councils
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?